Antitrust Antitrust

Drugmakers Advanz, Morningside see UK nitrofurantoin market-sharing probe closed

By Victoria Ibitoye
  • 08 Oct 2021 06:36
  • 08 Oct 2021 06:36
Drugmakers Advanz Pharma and Morningside, as well as wholesaler Alliance Healthcare, have seen a UK competition investigation into the supply of antibiotic drug nitrofurantoin closed down.

The Competition and Markets Authority said today it was closing the case, over allegations of carving up the market for the drug, on administrative grounds. The likely

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

LEARN MORE LEARN MORE

Latest News